The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.9M data for 1.2M Compounds and 9.3K Targets. Of those, 1,352K data for 627K Compounds and 4.5K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

12 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Identification of novel GLUT inhibitors.EBI
Bayer Pharma
Oxime-based inhibitors of glucose transporter 1 displaying antiproliferative effects in cancer cells.EBI
Universit£
Development of a novel class of glucose transporter inhibitors.EBI
The Ohio State University
Interaction of O-(undec-10-en)-yl-D-glucose derivatives with the Plasmodium falciparum hexose transporter (PfHT).EBI
Université
Structure guided design and synthesis of furyl thiazolidinedione derivatives as inhibitors of GLUT 1 and GLUT 4, and evaluation of their anti-leukemic potential.EBI
Bharati Vidyapeeth'S College of Pharmacy
Discovery and Optimization of Glucose Uptake Inhibitors.EBI
Kadmon
The Druggability of Solute Carriers.EBI
The Scripps Research Institute
Monosaccharide Analogues of Anticancer Peptide R-Lycosin-I: Role of Monosaccharide Conjugation in Complexation and the Potential of Lung Cancer Targeting and Therapy.EBI
TBA
Development of GLUT4-selective antagonists for multiple myeloma therapy.EBI
Emory University
(Aminoalkyl)carbamates of forskolin: intermediates for the synthesis of functionalized derivatives of forskolin with different specificities for adenylyl cyclase and the glucose transporter.EBI
Food and Drug Administration